Colonial Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Colonial Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,500	Closed	-$124K	–	1130
2025 Q2	$124K	Hold	1,500	–	–	0.02%	400
2025 Q1	$122K	Hold	1,500	–	–	0.02%	385
2024 Q4	$135K	Hold	1,500	–	–	0.02%	400
2024 Q3	$148K	Hold	1,500	–	–	0.02%	372
2024 Q2	$139K	Hold	1,500	–	–	0.02%	344
2024 Q1	$142K	Hold	1,500	–	–	0.03%	337
2023 Q4	$134K	Hold	1,500	–	–	0.03%	333
2023 Q3	$110K	Hold	1,500	–	–	0.03%	322
2023 Q2	$125K	Hold	1,500	–	–	0.03%	305
2023 Q1	$114K	Hold	1,500	–	–	0.03%	314
2022 Q4	$125K	Buy	+1,500	New	+$121K	0.03%	276

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Colonial Trust's XBI Position: Q3 2025 in Review

Colonial Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 1,500 shares — an estimated $124K sold.

Colonial Trust first reported a position in XBI in Q4 2022 and held it in 11 quarters. The position peaked at $148K in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Colonial Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Colonial Trust sold 1,500 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $124K.
Colonial Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 11 quarters.
Colonial Trust's State Street SPDR S&P Biotech ETF position peaked at $148K in Q3 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Colonial Trust's 13F filing for Q3 2025, filed 10 Nov 2025.